Literature DB >> 16087652

A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.

A Shrivastava1, M A von Wronski, A K Sato, D T Dransfield, D Sexton, N Bogdan, R Pillai, P Nanjappan, B Song, E Marinelli, D DeOliveira, C Luneau, M Devlin, A Muruganandam, A Abujoub, G Connelly, Q L Wu, G Conley, Q Chang, M F Tweedle, R C Ladner, R E Swenson, A D Nunn.   

Abstract

We describe a novel and general way of generating high affinity peptide (HAP) binders to receptor tyrosine kinases (RTKs), using a multi-step process comprising phage-display selection, identification of peptide pairs suitable for hetero-dimerization (non-competitive and synergistic) and chemical synthesis of heterodimers. Using this strategy, we generated HAPs with K(D)s below 1 nM for VEGF receptor-2 (VEGFR-2) and c-Met. VEGFR-2 HAPs bound significantly better (6- to 500-fold) than either of the individual peptides that were used for heterodimer synthesis. Most significantly, HAPs were much better (150- to 800-fold) competitors than monomers of the natural ligand (VEGF) in various competitive binding and functional assays. In addition, we also found the binding of HAPs to be less sensitive to serum than their component peptides. We believe that this method may be applied to any protein for generating high affinity peptide (HAP) binders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087652     DOI: 10.1093/protein/gzi049

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  19 in total

1.  Cell-specific targeting by heterobivalent ligands.

Authors:  Jatinder S Josan; Heather L Handl; Rajesh Sankaranarayanan; Liping Xu; Ronald M Lynch; Josef Vagner; Eugene A Mash; Victor J Hruby; Robert J Gillies
Journal:  Bioconjug Chem       Date:  2011-06-16       Impact factor: 4.774

Review 2.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

3.  Bacterial display enables efficient and quantitative peptide affinity maturation.

Authors:  Sophia A Kenrick; Patrick S Daugherty
Journal:  Protein Eng Des Sel       Date:  2010-01       Impact factor: 1.650

4.  Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).

Authors:  Jessica Bzyl; Wiltrud Lederle; Anne Rix; Christoph Grouls; Isabelle Tardy; Sibylle Pochon; Monica Siepmann; Tobias Penzkofer; Michel Schneider; Fabian Kiessling; Moritz Palmowski
Journal:  Eur Radiol       Date:  2011-05-12       Impact factor: 5.315

5.  SORTCERY-A High-Throughput Method to Affinity Rank Peptide Ligands.

Authors:  Lothar Luther Reich; Sanjib Dutta; Amy E Keating
Journal:  J Mol Biol       Date:  2014-10-12       Impact factor: 5.469

6.  Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [99mTc] (AH-113018) or Cy 5** (AH-112543) Labeled Peptide.

Authors:  Elaine M Jagoda; Sibaprasad Bhattacharyya; Joseph Kalen; Lisa Riffle; Avrum Leeder; Stephanie Histed; Mark Williams; Karen J Wong; Biying Xu; Lawrence P Szajek; Osama Elbuluk; Fabiola Cecchi; Kristen Raffensperger; Meghana Golla; Donald P Bottaro; Peter Choyke
Journal:  Mol Imaging       Date:  2015       Impact factor: 4.488

Review 7.  Peptide heterodimers for molecular imaging.

Authors:  Yongjun Yan; Xiaoyuan Chen
Journal:  Amino Acids       Date:  2010-03-16       Impact factor: 3.520

8.  High throughput profiling of serum phosphoproteins/peptides using the SELDI-TOF-MS platform.

Authors:  Lin Ji; Gitanjali Jayachandran; Jack A Roth
Journal:  Methods Mol Biol       Date:  2012

9.  Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.

Authors:  Sunitha V Bachawal; Kristin C Jensen; Amelie M Lutz; Sanjiv S Gambhir; Francois Tranquart; Lu Tian; Jürgen K Willmann
Journal:  Cancer Res       Date:  2013-01-17       Impact factor: 12.701

10.  Discovery of high-affinity protein binding ligands--backwards.

Authors:  Chris W Diehnelt; Miti Shah; Nidhi Gupta; Paul E Belcher; Matthew P Greving; Phillip Stafford; Stephen Albert Johnston
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.